verapamil has been researched along with clentiazem in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grupp, G; Grupp, I; Heikkila, J; Luomanmaki, K; Pesola, MK; Ramo, MP; Schroder, T | 1 |
| Rampe, D; Triggle, DJ; Zheng, W | 1 |
| Alam, R; Dash, PK; Kataoka, S; Yatsu, FM | 1 |
3 other study(ies) available for verapamil and clentiazem
| Article | Year |
|---|---|
Cardiac glycosides in the treatment of experimental overdose with calcium-blocking agents.
Topics: Animals; Atropine; Calcium; Calcium Channel Blockers; Calcium Gluconate; Depression, Chemical; Digoxin; Diltiazem; Dogs; Drug Overdose; Electrocardiography; Female; Hemodynamics; Humans; Male; Myocardium; Verapamil | 1992 |
Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Isradipine; Male; Myocardium; Potassium; Pyrroles; Radioligand Assay; Rats; Vasoconstriction; Verapamil | 1991 |
Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists.
Topics: Animals; Calcium Channel Blockers; Cell Division; Cells, Cultured; Diltiazem; DNA Replication; Growth Inhibitors; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Muscle, Smooth, Vascular; Myristoylated Alanine-Rich C Kinase Substrate; Nifedipine; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Protein Processing, Post-Translational; Proteins; Rats; Transcription Factor AP-1; Verapamil | 1997 |